Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...

Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials.

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Casuistic, we here report a nine-year old Danish girl with HIBCHD treated with intravenous high-dose methylprednisolone when presenting with encephalopathy during acute metabolic crisis. Presentation ...

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...

While compounded medications like this use ingredients that are Food and Drug Administration (FDA) approved in other medications, this specific product isn’t FDA approved. There are a lot of ...

The best Android tablets can do it all. They pack enough power to run apps and games with minimal or no slowdown. They're also energy-efficient enough to last long on a single charge. And when ...

is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this cheaper Viagra alternative and whether it’s as effective as the brand-name drug.

People may take salt tablets to help replenish low levels of sodium in the body. They are available over the counter in health stores and online. This article looks at when people use salt tablets ...

Brian Pacheco New York The writer is the managing director of communications for the Drug Policy Alliance. To the Editor: Nicholas Kristof’s column starts with a faulty and harmful premise ...